Helicobacter pylori infection in healthy people: a dynamic process?
B Meyer1, B Werth, C Beglinger
1Division of Gastroenterology, University Hospital, Basel, Switzerland.
Many healthy individuals possess antibodies against Helicobacter pylori (anti-Hp), but not necessarily active infection. This suggests spontaneous H. pylori elimination is common, unlike in ulcer patients.
Area of Science:
- Gastroenterology
- Microbiology
- Immunology
Background:
- Serological studies indicate a high prevalence of antibodies against Helicobacter pylori (anti-Hp) in healthy populations.
- The clinical significance of anti-Hp antibodies remains unclear, with uncertainty regarding active infection versus past exposure.
Purpose of the Study:
- To investigate the correlation between anti-Hp antibody presence and active Helicobacter pylori infection in healthy volunteers.
- To explore the implications of H. pylori eradication in the pathogenesis of peptic ulcer disease.
Main Methods:
- Enzyme-linked immunosorbent assay (ELISA) was used to determine anti-Hp antibody titers in 100 healthy volunteers.
- The 13C-urea breath test was employed concurrently to detect active H. pylori infection.
Main Results:
- 49% of participants exhibited high anti-Hp antibody titers.
- Only 24% of participants tested positive for active H. pylori infection.
- A significant discrepancy between antibody presence and active infection was observed.
Conclusions:
- A substantial number of healthy individuals appear to spontaneously clear Helicobacter pylori infections.
- The inability to eliminate H. pylori may be a critical factor in the development of peptic ulcer disease.
More Related Videos
10:44One-step Negative Chromatographic Purification of Helicobacter pylori Neutrophil-activating Protein Overexpressed in Escherichia coli in Batch Mode
Published on: June 18, 2016
05:23Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
Published on: March 7, 2025
Related Concept Videos
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds to M3...
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Peptic Ulcer
Gastritis II: Pathophysiology
Peptic Ulcer Disease II: Pathophysiology
